• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·SMMT
Held by 2 Gurus
Share

Summit Therapeutics Inc. Stocks

$ 11.82Last Updated 16.11.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 11.29B

In Guru Portfolios

Steven Cohen

Portfolio Weight (%)

0.1%

Change

+0.04%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Steven CohenPoint72 Asset Management, L.P.0.1%+0.04%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Trending

17.11.2026 19:10

Anthropic received a "buy" recommendation ahead of its IPO. What convinced the analyst?

17.11.2026 18:44

Shares of a biotech company backed by AstraZeneca plummeted following the FDA's rejection. Should you sell?

17.11.2026 18:23

Griffin, Soros, Jones: Which Billionaire Reduced Their Stake in Nvidia Before the Crash?

17.11.2026 17:50

Intel is no longer the largest asset in Nvidia's portfolio. What about investments in neo-clouds?

17.11.2026 16:48

Druckenmiller sold his shares in chipmakers and invested in SpaceX and Palantir

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026